Research

NeurogesX Submits Supplemental new Drug Application for Qutenza (R) 8% Patch for HIV-Associated Peripheral Neuropathy

Biopharmaceutical company, NeurogesX, announced it submitted a supplemental new drug to the US FDA seeking to expand the label to include an application for the management of pain due to HIV-associated neuropathy. FDA Priority Review status is given to drug candidates that offer major advances in treatment and accelerated the standard review time. HIV-PN is …

NeurogesX Submits Supplemental new Drug Application for Qutenza (R) 8% Patch for HIV-Associated Peripheral Neuropathy Read More »

Olive Leaf Extract May Help Fight Early-Diabetes Nerve Damage, Pain

At Kerman University of Medical Sciences in Kerman, Iran, researchers investigated the possible effects of olive leaf extract on in vitro and in vivo models of diabetic peripheral neuropathy. Their results suggest that olive leaf extract inhibits high glucose-induced neural damage and suppresses diabetes-induced thermail hyperalgesia, an increased sensation to pain. READ MORE Source: PubMed

U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage

Univeristy of Michigan neurologist, David Fink, MD, leads the team studying treatment for nerve damage related to diabetes and chemotherapy. They will join Diamyd Inc. in a project funded by the NIH to develop a new treatment for preventing nerve damage. “This is a case of ‘bench to bedside’ research,” Dr. Fink says. READ MORE …

U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage Read More »

Conquer Cancer Foundation Presents Award to Dr. Schneider for his Research in Breast Cancer Patients

Dr. Bryan Schneider, MD, associate professor of medicine at Indiana University School of Medicine, was announced as the recipient of a $450,000 grant to further his research on the relationship between taxane-induced neuropathy and clinical outcomes with other chemotherapy treatments. About one-third of patients who receive chemotherapy with a taxane develop neuropathy. His research aims …

Conquer Cancer Foundation Presents Award to Dr. Schneider for his Research in Breast Cancer Patients Read More »

cannabis for nerve pain

Marijuana Extract Might Help Prevent Chemotherapy-Related Nerve Pain

Cannabidiol – a compound derived from marijuana – may be a promising new treatment to prevent the development of painful neuropathy in patients receiving the chemotherapy drug paclitaxel. These results were published in Anesthesia & Analgesia based on animal experiments performed at Temple University School of Pharmacy, Philadelphia. READ MORE Source: Newswise

Rosiglitazone Investigated for Neuropathic Pain

The diabetes drug rosiglitazone (Avandia) is now being explored as a pain medication. The drug was initially controversial with some experts wanting to banish it and others wanting very tight restrictions. In a study that will be published in Anesthesia and Analgesia, a team from Juntendo University School of Medicine in Tokyo, Japan, has some new …

Rosiglitazone Investigated for Neuropathic Pain Read More »

Increased Nerve Fiber Density after Dietary Management with a Medical Food

A new study published by Pamlab, LLC, in the Review of Neurological Diseases measured epidermal nerve fiber density (ENFD) after using a nutritional management product, Metanx. Dispensed by prescription, the medical food offers a nutritional benefit by improving and maintaining blood flow in the vessels that carry important nutrients and oxygen to the peripheral nerves. READ MORE …

Increased Nerve Fiber Density after Dietary Management with a Medical Food Read More »

Lpath Addresses Diabetic Neuropathic Pain with Financial Support by NIH

Lpath announced on August 15 the Type 1 Diabetes Preclinical Testing Program of the NIH will provide support for the further study of Lpathomab’s efficacy in animal models of disease, particularly diabetic neuropathy. Lpathomab functions like a ‘molecular sponge’ that binds to, and neutralizes, the bioactive lipid signaling molecule, thus silencing receptors associated with the …

Lpath Addresses Diabetic Neuropathic Pain with Financial Support by NIH Read More »